BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/13/2020 9:39:45 PM | Browse: 171 | Download: 438
Publication Name World Journal of Critical Care Medicine
Manuscript ID 51981
Country India
Category Critical Care Medicine
Manuscript Type Observational Study
Article Title Experience with hemoadsorption (CytoSorb<sup>®</sup>) in the management of septic shock patients
Manuscript Source Unsolicited Manuscript
All Author List Yatin Mehta, Chitra Mehta, Ashish Kumar, Joby V George, Aditi Gupta, Saurabh Nanda, Gaurav Kochhar and Arun Raizada
Funding Agency and Grant Number
Corresponding Author Yatin Mehta, FRCA, MD, MNAMS, Doctor, Institute of Critical care and Anesthesia, Medanta The Medicity, Sector 38, Gurgaon 122006, Haryana, India. yatin.mehtacriticalcare@gmail.com
Key Words Hemoadsorption; Sepsis; Cytokines; Clinical conditions; Inflammation and extracorporeal;
Core Tip CytoSorb® is a promising new extracorporeal cytokine hemoadsorption device that can modulate the cytokine storm during sepsis. This retrospective study evaluated clinical outcomes after CytoSorb® therapy of 100 patients admitted to intensive care unit with sepsis. We observed a significant reduction in vasopressors dosage in 40 patients who survived. The survivors also had a reduction in all the biomarker levels (procalcitonin, C-reactive protein, serum lactate and bilirubin) and inflammatory markers (interleukin 6, interleukin 10 and tumour necrosis factor) after CytoSorb® therapy. Notably, 28% of patients who were given CytoSorb® therapy < 48 h after onset of septic shock survived.
Citation Mehta Y, Mehta C, Kumar A, George JV, Gupta A, Nanda S, Kochhar G, Raizada A. Experience with hemoadsorption (CytoSorb®) in the management of septic shock patients. World J Crit Care Med 2020; 9(1): 1-12
Received
2019-10-11 11:38
Peer-Review Started
2019-10-11 11:38
To Make the First Decision
2019-11-04 00:32
Return for Revision
2019-11-05 00:24
Revised
2019-12-23 15:06
Second Decision
2020-01-13 10:41
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-01-13 21:39
Articles in Press
2020-01-13 21:39
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2020-01-16 09:05
ISSN 2220-3141(online)
Open Access
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com